Abstract
BackgroundIntravenous immunoglobulin (IVIG) is known to have beneficial effects in rheumatological conditions with inflammatory myopathy including myositis overlap in systemic sclerosis (SSc).ObjectivesThis study is aimed to assess the efficacy of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
